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The present report develops our previous structural data concerning the cyanogen bromide fragments from 
the bovine nasal cartilage proteoglycan monomers. Among the reported sequences a Met-Ile-Trp-His se 
quence was characterized, useful for future studies devoted to the molecular cloning of the proteoglycan 
monomers. 
Sequence Cartilage Proteoglycan Probe 
1. INTRODUCTION 
Structural studies devoted to the protein core of 
the bovine nasal cartilage proteoglycan monomers 
have only recently been developed. The polydisper- 
sity of these compounds [l-3], mainly due to their 
level of glycosylation, appeared to be a major dif- 
ficulty for such research. However, while 
heterogeneous, the protein core of the monomers 
possesses ome regions which could give rise to 
fragments sufficiently homogeneous for primary 
structure studies. We reported the isolation of 
homogeneous cyanogen bromide (CNBr) frag- 
ments from the hyaluronic acid-binding region of 
the monomers and from the monomers themselves 
[4,5]. No sequence among those which have 
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Research Conference on Proteoglycans, Plymouth 
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already been determined seemed to constitute a 
useful tool for future structural studies concerning 
the gene implicated in the protein core biosyn- 
thesis. We report additional data concerning the 
CNBr fragments obtained from the monomers. 
One of them is of special interest as the synthesis 
of an oligonucleotide probe, based on its structure, 
can now be considered. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Guanidine hydrochloride (Gdn-HCl) was from 
Jannsen Chemica. Benzamidine hydrochloride, 
cyanogen bromide, suprapur cesium chloride and 
anisole were from Merck. Aminohexanoic acid, 
ethylenediaminetetraacetic acid @sodium salt) 
and chondroitinase ABC (EC 4.2.2.4) were from 
Sigma and hydrogen fluoride/pyridine from 
Fluka. Sepharose CL-6B was from Pharmacia. All 
other reagents (analytical grade) were from Pro- 
labo, Labo Disc or CanaIco. 
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2.2. Analytical procedures 
Sodium dodecyl sulfate-polyacryl~ide gel 
electropboreses (SDS-PAGE) were performed ac- 
cording to [6] (12 and 6% polyacrylamide, pH 
8.9); protein bands were stained with Coomassie 
brilliant blue R-250. Automated Edman degrada- 
tion was carried out in a 890 C Beckman Se- 
quencer by the 1 M quadrol single cleavage 
method; the phenylthiohydantoin-amino acids 
were characterized by thin-layer chromatography 
(chloroform/methanol 90 : 10, v/v; pure chloro- 
form) and by high-performance liquid chromato- 
graphy ~aters~hromato~aph, model ALC/ 
GPC 204) on a 30 cm Waters ~-Bondap~ Cl8 
column. 
2.3. Preparative procedures 
Proteoglycan monomers were sequentially ex- 
tracted as in {7]; they were obtained from the pro- 
teoglycan complex fraction (Al) from the Gdn- 
HCl extract and isolated after CsCl density gra- 
dient centrifugation under dissociative conditions. 
3.4 g (dry weight) of monomers were submitted to 
CNBr treatment as in [5] and the reaction mixture, 
after concentration, was subjected to CsCl density 
gradient centrifugation as in 151. The lower half of 
the gradient (bottom fraction) contained the totali- 
ty of the uronates of the starting material: it cor- 
responded to the CN-1 fraction [S]; the upper half 
(top fraction) contained the CN-2 and CN-3 frac- 
tions [S]. Chondroitinase treatment was carried 
out as in [5]. Hydrogen fluoride/pyridine treat- 
ment in presence of anisole was performed accor- 
ding to [S] for 5 h at room temperature. Sepharose 
CL-6B gel filtration was performed with a 0.05 M 
CH&OONa, 4 M Gdn-HCl, pH 5.8, buffer as 
eluent. Preparative SDS-PAGE was performed as 
in 143. 
3. RESULTS AND DISCUSSION 
3.1. Study of the fragments contained in the top 
fraction (CN-2 and CN-3) 
The CN-2 and CN-3 fractions were separated by 
Sepharose CL-63 gel filtration (not shown). 
One major component, embedded in a diffuse 
stained zone, was characterized in the CN-3 frac- 
tion by 12% analytical SDS-PAGE; its relative 
molecular mass was 19.5 kDa (fig.1, gel 4). 
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Fig.1. SDS-PAGE of the reduced and alkylated CN-2 
and CN-3 fractions on 6 and 12% gels. CN-2 fraction: 
gels 1 and 3; CN-3 fraction: gels 2 and 4. 
When submitted to 12% analytical SDS-PAGE, 
the unreduced CN-2 fraction did not give rise to 
any gel penetrating component (not shown). Upon 
reduction, 3 fragments with molecular masses of 
13, 24.5 and 29 kDa, respectively, were 
characterized ona 12% gel (fig.1, gel 3); 150 kDa 
was assigned to he broad 6% gel penetrating band 
(fig.1, gel 1). The 13, 24.5 and 29 kDa fragments 
appeared to be linked by d&&fide bonds to the 
150 kDa component. The latter corresponds tothe 
previously described CN-2 RA/6B-1 fraction 151. 
The separation of the 4 fragments was achieved, 
after reduction and alkylation, by Sepharose 
CL-6B gel filtration and preparative SDS-PAGE 
(not shown). The N-terminal amino acid sequences 
of these different fragments are reported in table 1. 
The 150 kDa fragment was studied before and 
after deglycosylation. According to previous 
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Table 1 
N-terminal sequences of CNBr-fragments isolated from the CN-2 fraction 
October 1984 
Fragment 
13 kDa 
10 20 
Glu-Gly-Glu-Val-Phe-Tyr-Ala-Thr-Ser-Pro-Glu-Lys-Phe-Thr-Phe-Gln-Glu-Ala-Ala-Asn- 
30 
Glu-Cys-Arg-Arg-Leu-Gly-Ala-Arg-Leu-Ala- 
24.5 kDa 
10 20 
Ser-Gly-Ile-Glu-Asp-Ser-Gln-Ala-Thr-Leu-Glu-V~-Val-Val-Lys-Gly-Ile-V~-Phe-His- 
30 
Tyr-Arg-Ala-Ile-Ser-Cys-Arg-Tyr-Thr-Leu- 
29 kDa 
150 kDa 
10 
Ser-Gly-Ile-Glu-Asp-Ser-Gln-Ala-Thr-Leu-Glu-Val-Val-Val-Lys-Gly- 
10 
Ser-Ser-Ala-Gly-Trp-Leu-Ala-Asp-Arg-Ser-V~-~g-T~-Pro-Ile-~r- 
results [4,9] the 13, 24.5 and 29 kDa fragments 
arise from the hyaluronic acid-binding region. 
3.2. Study of the fragments contained in the 
bottom fraction (CN-I) 
No gel penetrating band could be detected by 12 
or 6% SDS-PAGE with either unreduced or 
reduced samples of the CN-1 fraction (fig.2, gels 
2). Upon chondroitinase treatment, a gel pene- 
trating band was characterized on 12 and 6% gels 
(fig.2, gels 3 not reduced); a large amount of 
material still did not penetrate into the gel. After 
subsequent reduction and alkylation, an additional 
band was characterized on a 12% gel (fig.2, gel 3, 
reduced); its molecular mass was 15 kDa. The 
molecular mass of the diffuse 6% gel penetrating 
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Fig.2. SDS-PAGE of the CN-1 fraction on 6 and 12% gels. Chondroitinase ABC alone: gels 1; CN-1 fraction: gels 
2; chondroitinase-treated CN-1 fraction: gels 3. 
39 
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Fig.% Sepharose CLdB gel filtration of the chondroitinase-treated CN-1 fraction. The SDS-PAGE were performed 
on 6 and 12% gels with unreduced (N) or reduced (R) samples of the two isolated peaks. 
band characterized on a reduced sample was 
150 kDa. The separation of these fragments was 
achieved by a two-step Sepharose CL-6B gel filtra- 
tion. During the first, the unreduced chondroitin- 
ase-treated CN-1 fraction gave rise to two fractions 
(fig.3). In the first eluted peak (CN-1 C/6B-1) no 
gel penetrating material could be detected; the se- 
cond peak (CN-1 C/6&2) contained the 150 kDa 
fragment; upon reduction and alkylation of the 
latter the 15 kDa fragment was liberated and its 
separation was achieved by a second gel filtration 
(fig.4). 
The occurrence of the 15 kDa fragment has 
already been observed upon CNBr treatment of 
40 
chondroitinase-treated monomers; it was not 
detected in the hyaluronic acid-~mding region [9]. 
Its N-terminal sequence isreported in table 2. This 
CNRr-fragment isof special interest, as from its N- 
terminal area the occurrence of a Mu-Ile-To-His 
sequence was deduced, convenient for the syn- 
thesis of an oligonucl~tide probe. 
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Fig.4. Sepharose CL-6B gel filtration of the reduced and alkylated CN-1 C/dB-2 fraction. The SDS-PAGE were 
performed.on 6% gels. 
Table 2 
N-termhml amino acid sequence of the 15 kDa fragment isolated from the CN-1 fraction 
1 10 20 
Ile-Trp-His-Glu-Lys-Gly-Glu-Trp-Asn-Asp-V~-Pro-Cys-~n-T~-Gln-Leu-Pr~Phe-~- 
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